Home › Trial NCT01511822
Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance
- Trial IDNCT01511822
- StatusCompleted
- PhasePhase 4
- Study typeInterventional
- SponsorAGUNCO Obstetrics and Gynecology Centre
- Enrollment—
- Start date—
- ConditionsPCOS · Polycystic Ovary Syndrome
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.